News

Talotrexin (PT-523), a novel nonpolyglutamatable antifolate drug, is currently being evaluated in a phase I/II multicenter clinical trial in patients with relapsed or refractory acute lymphoblastic leukemia (ALL).

Study 09 is a randomized, double-blind, placebo-controlled study being conducted in Europe. The primary endpoint is the proportion of patients with at least a 50% improvement in the

The SkyePharma-developed version of the drug is designed to have an improved pharmacokinetic profile and is expected to replace the current version and to expand the market opportunity

The technique, known as ultrasound-targeted microbubble destruction (UTMD), delivers insulin genes to the organ via microscopic ‘bubbles.’ Once the bubbles reach their target, they are burst with ultrasound,

The data was presented at the 101st American Urological Association (AUA) annual meeting held in Atlanta, Georgia. In the study, independent investigators from Ulm, Germany, and Boston, Massachusetts,

Novavax' testosterone medicine, which is applied as a lotion, is currently in phase II clinical development. Esprit will receive exclusive rights to market the product in North America.

According to an internal FDA communication first reported in the Wall Street Journal, the FDA has received reports of 12 cases of liver failure, including four deaths, in

Lescol and Lescol XL are indicated for the treatment of hypercholesterolemia and mixed hyperlipidemia in conjunction with a diet low in saturated fat and cholesterol. Lescol is also

This move represents the first triptan that can be given without a prescription in the UK and highlights the government's commitment to expand the range of medicines available